Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23696269 | 0.88 | CYP2D6 (0.46) | CYP2D6SMN1; SMN2 | |
| SCHEMBL25654355 | 0.84 | CYP2D6 (0.31) | CYP2D6 | |
| SCHEMBL25725785 | 0.83 | CYP2D6 (0.43) | CYP2D6SMN1; SMN2 | |
| SCHEMBL22848539 | 0.81 | KDM4E (0.32) | CYP2D6 | |
| SCHEMBL22794150 | 0.80 | CYP2D6 (0.32) | CYP2D6 | |
| SCHEMBL24673175 | 0.79 | DRD2 (0.34) | — | |
| SCHEMBL25888535 | 0.79 | CYP2D6 (0.35) | CYP2D6SMN1; SMN2 | |
| SCHEMBL23560024 | 0.78 | OPRD1 (0.33) | CYP2D6 | |
| SCHEMBL25727129 | 0.78 | — | — | |
| SCHEMBL24673419 | 0.77 | CYP2D6 (0.32) | CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219945-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219945-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | CYP2D6 3599/4885SMN1; SMN2 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.